These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 114063)

  • 21. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of central acting drugs on prolactin release in young and old male rats.
    Forman LJ; Sonntag WE; Miki N; Ramos T; Meites J
    Proc Soc Exp Biol Med; 1981 Jul; 167(3):354-8. PubMed ID: 6454894
    [No Abstract]   [Full Text] [Related]  

  • 23. Iontophoresis of morphine into the arcuate nucleus: effects on dopamine concentrations in hypophysial portal plasma and serum prolactin concentrations.
    Haskins JT; Gudelsky GA; Moss RL; Porter JC
    Endocrinology; 1981 Mar; 108(3):767-71. PubMed ID: 7460840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
    Demarest KT; Moore KE; Riegle GD
    Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep pattern alterations by naloxone. Partial prevention by haloperidol.
    Cianchetti C; Masala C; Olivari P; Giordano G
    Psychopharmacology (Berl); 1984; 83(2):179-82. PubMed ID: 6431470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between locomotor stimulation and the electrophysiological effects of low doses of morphine on substantia nigra dopamine neurons. I. Acute drug administration.
    Ostrowski NL; Caggiula AR
    J Pharmacol Exp Ther; 1991 Apr; 257(1):72-81. PubMed ID: 2020010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of tolerance to the prolactin-releasing action of morphine and its modulation by hypothalamic dopamine.
    Deyo SN; Swift RM; Miller RJ; Fang VS
    Endocrinology; 1980 May; 106(5):1469-74. PubMed ID: 7363859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyridoxine (Vit. B6) decreases opioids-induced hyperprolactinemia.
    Vescovi PP; Gerra G; Rastelli G; Ceresini G; Moccia G
    Horm Metab Res; 1985 Jan; 17(1):46-7. PubMed ID: 3967846
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of morphine, methadone, nalorphine and naloxone on responding under schedules of electric shock titration.
    Smith JB; McKearney JW
    J Pharmacol Exp Ther; 1977 Mar; 200(3):508-15. PubMed ID: 403279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gamma-aminobutyric acid and histamine on prolactin secretion in the rat.
    Rivier C; Vale W
    Endocrinology; 1977 Aug; 101(2):506-11. PubMed ID: 407071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postictal prolactin elevations in rats.
    Swartz CM; Dunbar E
    Neuropsychobiology; 1983; 10(1):1-6. PubMed ID: 6657033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phencyclidine suppresses plasma prolactin levels.
    Saller CF; Zerbe RL; Bayorh MA; Lozovsky D; Kopin IJ
    Eur J Pharmacol; 1982 Sep; 83(3-4):309-11. PubMed ID: 7173312
    [No Abstract]   [Full Text] [Related]  

  • 34. Naloxone-induced electrographic seizures in the primate.
    Snyder EW; Shearer DE; Beck EC; Dustmann RE
    Psychopharmacology (Berl); 1980; 67(3):211-4. PubMed ID: 6770398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative naloxone effects on serum-prolactin.
    Janowsky D; Judd L; Huey L; Roitman N; Parker D; Segal D
    Lancet; 1978 Sep; 2(8090):637. PubMed ID: 80568
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum prolactin as an index of dopamine receptor blockade in acute schizophrenia [proceedings].
    Cotes PM; Crow TJ; Johnstone EC
    Br J Clin Pharmacol; 1977 Oct; 4(5):651P. PubMed ID: 911637
    [No Abstract]   [Full Text] [Related]  

  • 37. Naloxone and ECT-induced prolactin release.
    Swartz CM
    Psychiatry Res; 1988 Apr; 24(1):119-21. PubMed ID: 3393615
    [No Abstract]   [Full Text] [Related]  

  • 38. Naloxone lowers plasma-prolactin in man.
    Rubin P; Swezey S; Blaschke T
    Lancet; 1979 Jun; 1(8129):1293. PubMed ID: 87748
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of dopamine receptor agonists on prolactin secretion in childhood migraine.
    D'Andrea G; Cananzi AR; Grigoletto F; Meneghini F; Cortesi S; Soffiati G; Joseph R; Nordera G; Ferro-Milone F
    Headache; 1988 Jun; 28(5):354-9. PubMed ID: 3403257
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-induced changes in prolactin secretion. Clinical implications.
    Hell K; Wernze H
    Med Toxicol Adverse Drug Exp; 1988; 3(6):463-98. PubMed ID: 3063922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.